Journal of Pancreatic Cancer is the only peer reviewed journal focused solely on pancreatic cancer. The Journal is international, and open access, publishing articles covering the clinical, translational and basic science of malignancies of the pancreas and the peripancreatic region.
Journal of Pancreatic Cancer provides a single open forum for communicating the advancement of science and treatments for pancreatic cancer. The Journal will be relevant for surgical oncologists, pancreatologists, gastroenterologists, radiation oncologists, medical oncologists, endocrinologists, pathologists, palliative care specialists, epidemiologists, immunologists or cancer researchers investigating problems and treatments for pancreatic cancer. The Journal publishes scientific studies on the clinical immunological, pathological, biological and other aspects of the disease. Topics considered range from molecular genetics to surgery and other therapeutic approaches and outcomes.
Journal of Pancreatic Cancer publishes under the Creative Commons Attribution 4.0 (CC BY) license and freely available online to ensure broad dissemination and participation. All articles in the Journal are rapidly reviewed and published online. Journal of Pancreatic is fully NIH-, HHMI- and Wellcome Trust compliant.
Journal of Pancreatic Cancer coverage includes:
- Pathological aspects
- Surgical techniques
- Innovative uses of novel technology or medical devices
- Genetic oncology
- Chemotherapy and drug therapy
- Radiation oncology
- Epidemiological information
- Molecular targeted therapy
- Alternative and complementary treatments
- Early detection
Journal of Pancreatic Cancer is under the editorial leadership of Charles Yeo, MD, FACS, Samuel D. Gross Professor and Chair of the Department of Surgery at the Sidney Kimmel Medical College of Thomas Jefferson University.
Audience: Pancreatologists, gastroenterologists, surgical oncologists, radiation oncologists, pathologists, physicians, nurse practitioners, and palliative care providers
Benefits of publishing in Journal of Pancreatic Cancer:
- High visibility, immediate and unrestricted online access to published articles
- Rigorous and rapid peer review
- Easy compliance with open access mandates
- Authors retain copyright
- Highly indexed – citation tracking and inclusion in bibliographic databases
- Targeted email marketing
Director of Open Access Publishing
Mary Ann Liebert, Inc., publishers
140 Huguenot Street, 3rd Floor
New Rochelle, NY 10801
The views, opinions, findings, conclusions and recommendations set forth in any
Journal article are solely those of the authors of those articles and do not necessarily
reflect the views, policy or position of the Journal, its Publisher, its editorial
staff or any affiliated Societies and should not be attributed to any of them.